Q219 saw marginal revenue growth amid single-injection momentum and competitive pricing pressure

The numbers are in and now that we are in the second quarter of 2019, the US Joint Fluid market seems to be getting off its slow-ish start of the year, gaining some momentum with the single-injection segment pushing the aggregate total revenue into positive growth, according to the recently published SmartTRAK Financial Dashboard. This, despite relentless and fierce pricing competition in the multi-injection arena. 

Among the many topics covered in the Q219 US Joint Fluid Market Recap* are:

SmartTRAK was once again cited as a trusted source for market data, this time in the Orthofix Q219 Earnings Call and press release.

Brad Mason, Orthofix's President and Chief Executive Officer, referenced the SmartTRAK Market Recap: OrthoBio Report in the press release and stated “Regarding the second quarter results, net sales were in line with our expectations, led by another quarter of outstanding performance in our Biologics products and notably, as reported by SmartTRAK ^®, Orthofix now has the number one market share position in the U.S. cellular allograft segment.”

Terry Hayslett is SmartTRAK's Senior Analyst, Advanced Wound Care. Terry has 20+ years of diverse healthcare experience, including provider reimbursement, corporate compliance, business development, strategic planning, financial analysis and health economics. Before joining SmartTRAK, Terry was  responsible for the global funding and reimbursement function at Mölnlycke Health Care. 

As a Senior Analyst for Wound Care, Terry will manage and maintain the US & WW External Devices (NPWT, Energy, Oxygen and Debridement) and Compression modules and provide reimbursement and regulatory support across all AWC modules.

Meet Terry Hayslett:

1. What is your role with SmartTRAK? As a Senior Analyst for Wound Care, my role is to manage and maintain the US & WW External Devices (NPWT, Energy, Oxygen and Debridement) and Compression modules. I also provide reimbursement and regulatory support across all AWC modules.

The SmartTRAK analyst team is expanding and we are looking for an experienced and motivated individual who would like to manage one or more of our Advanced Wound Care modules, with a focus on the European markets. As you know, all of our SmartTRAK analysts are former marketing, business development or competitive intelligence professionals with one of the major medical device manufacturers and, in fact, most have come to us via recommendations from our subscribers. We believe that having a person of this caliber with relevant experience and deep insight on the market is a tremendous value-add to the SmartTRAK platform.

Learn More and Apply

SmartTRAK Subscribers: See only news for the Markets, Modules and Segments and now TYPES of content that you care about!

Have you ever wished that you could customize your SmartTRAK Daily Updates Email so that you can see ONLY news about the SmartTRAK Markets, Modules & Segments as well as Type of content that you care about (like skipping all the Patent updates)?

And that you could save yourself time from scrolling through all the Markets, Modules and Segments that your company subscribes to? 

SmartTRAK was cited once again as a trusted source for data in a press release from Smith & Nephew entitled "Smith & Nephew meniscal knee repair technology delivers 0% re-operation rate and 100% meniscal healing at six months shows first ever study of horizontal cleavage tears".

SmartTRAK is excited to be attending the Society of Neurointerventional Surgery’s (SNIS) 16th Annual Meeting in Miami, Florida from July 22-25, 2019. Anne Staylor, Managing Editor, Business Intelligence and Senior Director, Advanced Technologies will be covering the latest news at the conference, and will be providing updates on key studies, trends, and technologies affecting the market for ischemic and hemorrhagic stroke devices. 

BioMedGPS, developer of SmartTRAK Business Intelligence, has been recognized by the Orange County Business Journal (OCBJ) as one of the largest women-owned firms in Orange County, CA.

SmartTRAK identifies trends to watch in Spine

By most accounts, the Spine market has stabilized with modest low single-digit growth expected this year. Medtronic CEO Omar Ishrak agrees that the Spine market seems to have stabilized and is starting to inch back up. However, he suggests that it is still slower than a year or two ago as price declines are now offsetting procedure growth, resulting in flat to low single-digit to growth. For 2019, Needham analysts are modeling 2% spine market growth with overall orthopedic market growth of 3.4%.

New strategic alliance expands SmartTRAK market research capabilities

BioMedGPS, developer of SmartTRAK Business Intelligence, is excited to announce a new strategic partnership with Quomeda, a widely respected international healthcare research consultancy firm located in the UK.  Through this new alliance, SmartTRAK has expanded its suite of strategic advisory services globally to include custom consulting as well as provider, hospital and procedural volume data.